Related references
Note: Only part of the references are listed.Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype
Helene R. McMurray et al.
NATURE (2008)
Endothelial cells enhance tumor cell invasion through a crosstalk mediated by CXC chemokine signaling
Kristy A. Warner et al.
NEOPLASIA (2008)
Curcumin downregulates the inflammatory cytokines CXCL1 and-2 in breast cancer cells via NF kappa B
Beatrice E. Bachmeier et al.
CARCINOGENESIS (2008)
Chemokines in tumor angiogenesis and metastasis
Seema Singh et al.
CANCER AND METASTASIS REVIEWS (2007)
Mutant p53 attenuates the SMAD-dependent transforming growth factor β1 (TGF-β1) signaling pathway by repressing the expression of TGF-β receptor type II
Eyal Kalo et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells
Wensheng Yan et al.
CANCER RESEARCH (2007)
Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion
S. A. Mehta et al.
ONCOGENE (2007)
Transcription regulation by mutant p53
L. Weisz et al.
ONCOGENE (2007)
Mutant p53 enhances nuclear factor κB activation by tumor necrosis factor α in cancer cells
Lilach Weisz et al.
CANCER RESEARCH (2007)
Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1
K. I. Amiri et al.
ONCOGENE (2006)
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
DZ Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both smad and c-jun NH2-terminal kinase pathways
SX Yang et al.
CANCER RESEARCH (2006)
Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis
M Caunt et al.
CANCER RESEARCH (2006)
A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer
B Wang et al.
CANCER RESEARCH (2006)
Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix
T Engl et al.
LIFE SCIENCES (2006)
The chemokine GRO-α (CXCL1) confers increased tumorigenicity to glioma cells
Y Zhou et al.
CARCINOGENESIS (2005)
Tumor-derived p53 mutants induce NF-κB2 gene expression
MJ Scian et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-κB and CXC chemokines
E Karl et al.
CANCER RESEARCH (2005)
KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway
M Burger et al.
ONCOGENE (2005)
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
GA Lang et al.
CELL (2004)
The gain of function of the p53 mutant Asp281Gly is dependent on its ability to form tetramers
A Atema et al.
CANCER LETTERS (2002)
Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma
BR Lane et al.
JOURNAL OF VIROLOGY (2002)
A system for stable expression of short interfering RNAs in mammalian cells
TR Brummelkamp et al.
SCIENCE (2002)
p21B, a variant of p21Waf1/Cip1, is induced by the p53 family
S Nozell et al.
ONCOGENE (2002)
Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms of CCAAT/enhancer-binding proteins
Y Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The role of CDP in the negative regulation of CXCL1 gene expression
C Nirodi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Growth regulated oncogene-α expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism
E Loukinova et al.
ONCOGENE (2000)
Share Paper
